Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.43 USD
Change Today +0.0193 / 4.70%
Volume 505.0K
STEM On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Stewart Craig Ph.D.

Former Executive Vice President of Manufacturing Operations & Regulatory Affairs, StemCells Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 4 different industries.

53--
As of Fiscal Year 2013

Background*

Dr. Stewart Craig, Ph.D., serves as Vice President of Manufacturing at Sangamo Biosciences Inc. Dr. Craig has over twenty-five years of experience in the biotechnology sector, the last 15 of which is in the cell therapy field. Dr. Craig served as an Executive Vice President of Manufacturing Operations & Regulatory Affairs at StemCells Inc. until May 2014. Dr. Craig served as Senior Vice President of Development and Operations at StemCells Inc. since September 15, 2008. ...

Read Full Background

Corporate Headquarters*

7707 Gateway Boulevard
Newark, California 94560

United States

Phone: 510-456-4000
Fax: 510-456-4001

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
Newcastle University
BS
Newcastle University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STEM:US $0.43 USD +0.0193

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Nick Leschly Chief Executive Officer, President and Director
bluebird bio, Inc.
$440.4K
André Choulika Ph.D.Co-Founder, Chairman and Chief Executive Officer
Cellectis S.A.
€328.4K
David M. Pernock Chairman, Chief Executive Officer and President
Fibrocell Science, Inc.
$490.0K
Jörn Aldag Chief Executive Officer, Managing Director and Member of Management Board
uniQure N.V.
€484.0K
Jeffrey D. Marrazzo M.B.A., M.P.A.Co-Founder, Chief Executive Officer and Director
Spark Therapeutics, Inc.
$349.6K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STEMCELLS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.